Torrent Pharma Q2 Profit Falls Nearly 10% as R&D Spending Rises
Torrent Pharmaceuticals reported a near 10% decline in second-quarter profit as higher research and development spending outweighed robust domestic demand for chronic therapies.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.